Obesity drugs show promise in cancer prevention

An American study found that the use of GLP-1 weight loss medications may reduce the risk of certain obesity-related cancers by up to 41%, with a greater decrease of 70% in men and 58% for endometrial cancer. The study involved over 161,000 people over two years and indicated that the benefits of these drugs might go beyond weight loss and blood sugar improvement, highlighting the need for further research into their role in cancer prevention.

articleDetails.fontSize.sizeحجم النص

تنويه: هذا ملخص تم إنشاؤه بواسطة الذكاء الاصطناعي

عرض المقال بالكامل